Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Anastrozole
Anastrozole
Inquiry
Post Date: | Nov 02,2015 |
Expiry Date: | Apr 30,2016 |
Detailed Description: |
Cas No. :120511-73-1
Detailed Product Description
Oral & Injectable Anabolic Steroid Hormones Anastrozole CAS 120511-73-1 Male Supplement With Anti-estrogen Arimidex Quick Details: •Anastrozole •Alias :Arimidex ,Tetramethyl-5-(1H-1,2,4-triazol-1ylmethyl)1,3-benzenediacetionitrile •CAS NO. : 120511-73-1 •Assay : 98%~102% •Appearance : White crystalline powder •Active life cycle : 6 hours •MF : C17H19N5 •MW : 293.37 •Grade : Pharmaceutical Grade •Storage: Shading, confined preservation •Manufacturer : Hezhong •Usage : Anastrozole is a potent non-steroidal aromatase inhibitors , which lead the decrease of plasma level of estrogen, inhibited the growth of breast cancer. For the treatment of advanced breast cancer in postmenopausal women patients. Description : Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer. Many breast cancers also contain aromatase; the importance of tumor-generated estrogens is uncertain. Treatment of breast cancer has included efforts to decrease estrogen levels by ovariectomy premenopausally and by use of anti-estrogens and progestational agents both pre- and post-menopausally, and these interventions lead to decreased tumor mass or delayed progression of tumor growth in some women. Anastrozole is a potent and selective non-steroidal aromatase inhibitor. It significantly lowers serum estradiol concentrations and has no detectable effect on formation of adrenal corticosteroids or aldosterone. Application: Three azole aromatase inhibitors are potent selective, it can inhibit the cytochrome P-450 dependent aromatase thereby blocking the biosynthesis of estrogen, but estrogen is the main factor that stimulates the growth of breast cancer cells. The treatment of breast cancer, especially for those with adjuvant hormone therapy after menopause after recurrence of women with advanced breast cancer. Effects : Anastrozole is more effective than previous drugs such as tamoxifen and crucially, it has fewer side effects . Anastrozole has been tested for reducing estrogens, including estradiol, in men. Some athletes and body builders use anastrozole as part of their steroid cycle to reduce and prevent symptoms of excess estrogen--gynecomastia, emotional lability and water retention. Bone weakness has been associated with anastrozole. |
CAS Registry Number: | 120511-73-1 |
Synonyms: | ;Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile;ICI-D-1033;Arimidex;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha',alpha'-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-;Anastrozol;Anatrozole;ZD-1033, ICI-D-1033, Arimidex;2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile;1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)- zd;1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl);2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile); |
Molecular Formula: | C17H19N5 |
Molecular Weight: | 293.37 |
Molecular Structure: |
Company: | HongKong Yuancheng Group Co.,Limited [ China ] |
Contact: | Phong |
Tel: | +86-027-50755989 |
Fax: | +86-027-50755989 |
Email: | phong@yccreate.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.